Second Line Capital »

Fs Global Cr Opportunitie Fda shares owned by Second Line Capital

Quarter-by-quarter ownership of Fs Global Cr Opportunitie Fda (FSCO) shares owned by Second Line Capital from 13F filings

Historical chart of Second Line Capital investment in Fs Global Cr Opportunitie Fda

Tip: Access up to 7 years of quarterly data

All positions including Fs Global Cr Opportunitie Fda held by Second Line Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Fs Global Cr Opportunitie Fda by Second Line Capital

Quarter filed Position value Share count Share price at filing
2025-09-30 $79k 12k 6.91
2025-06-30 $83k 12k 7.26

More positions owned by Second Line Capital

Etf Ser Solutions Aptus Collrd Inv (ACIO)
Etf Ser Solutions Aptus Defined (DRSK)
Etf Ser Solutions Aptus Int Enh Yl (IDUB)
Spdr Index Shs Fds Portfolio Devlpd (SPDW)
Etf Ser Solutions Aptus Drawdown (ADME)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Etf Ser Solutions Opus Sml Cp Vl (OSCV)
Etf Ser Solutions Aptus Enhanced (JUCY)
Applovin Corp Com Cl A (APP)
Invesco Exchange Traded Fd T S&p500 Eql Wgt (RSP)
Etf Ser Solutions Aptus Large Cap (DUBS)
Spdr Index Shs Fds Portfolio Emg Mk (SPEM)
Microsoft Corporation (MSFT)
NVIDIA Corporation (NVDA)
First Tr Exchange-traded First Tr Enh New (FTSM)

View all positions for Second Line Capital

Top funds holding Fs Global Cr Opportunitie Fda

Commonwealth Equity Services
Cambridge Investment Research Advisors
Cetera Investment Advisers
Sit Investment Associates
LPL Financial
Vista Finance
H D Vest Advisory Services
Blackstone Group
Rockefeller Capital Management
Advisor Group Holdings
Morgan Stanley
Summit Financial
Envestnet Asset Management
Thomas J. Herzfeld Advisors
Ellis Investment Partners

View all funds holding Fs Global Cr Opportunitie Fda